Vertex Pharmaceuticals (VRTX) Non-cash Items (2010 - 2011)
Vertex Pharmaceuticals (VRTX) recorded quarterly Non-cash Items of $12.2 million in Q4 2011, down 4.25% quarter-over-quarter from $12.8 million in Q4 2010, and down 4.25% on a YoY basis from $12.8 million in Q4 2010.
Vertex Pharmaceuticals (VRTX) Non-cash Items (2010 - 2011) Analysis & Trends
Vertex Pharmaceuticals' Non-cash Items history runs 2 years deep, the most recent figure standing at $12.2 million for Q4 2011.
- In Q4 2011, Non-cash Items fell 4.25% year-over-year to $12.2 million; the TTM figure through Dec 2011 stood at $12.2 million (down 4.25% YoY), while the FY2011 annual figure was $12.2 million, down 4.25% from the prior year.
- Non-cash Items was $12.2 million for Q4 2011 at Vertex Pharmaceuticals, down from $12.8 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $12.8 million in Q4 2010 to a low of $12.2 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 12.23 Mn |
| Dec 31, 2011 | 12.23 Mn |
| Dec 31, 2010 | 12.77 Mn |
| Dec 31, 2010 | 12.77 Mn |